As well as endless ramping Preefty has shown a fairly substantial lack of common sense here. I cannot see the sp drifting below 25p. There must be something on the horizon for the big buyers to be excited about, otherwise why would they be taking part.
Even if there is only a small rise to 30p over the next few months. I am almost certain there will be a higher exit possible than 25p. Jumping from this floor price into the latest ODX spike is absolutely bonkers.
"The £20k and £10k by Budd and Fowler is just an investment in securing their jobs for another 2 years minimum, so small price to pay. Don't forget they are on £400k and and £180k respectively, before bonus"
Not that it makes much difference but in the interests of accuracy I think DB got paid around £437k inclusive of bonus last year as per the November 2020 annual report. Rather than before bonus.
But yes I agree that the directors needed to show willing to buy into the placing to demonstrate confidence for bigger money to follow.
“All of the Company's Directors intend to participate in the Fundraising either via the Placing or the Open Offer. The £ sterling amount they each intend to subscribe for is as follows: David Budd - £20,000, Matthew Fowler - £10,000, Ian Gilham £10,000, Tom Lindsay - £15,000 and Chris Yates - £5,000.”
Look at the bigger picture toma.kyuch.
Can you imagine how it would be received by the city if they did not take part?
What has the company achieved by way of revenue on the back of the last 18 months work? The company needs to convince big money to buy into the placing. If the placing is not well subscribed then where is the operating capital going to come from?
"Stars i'd agree, but it's pointless if you only start delivering ince sentiment has gone. Look at NCYT at as an example, reached £12 at the height of Covid with it's PCR yet now introducing LFT's has 10's of millions in the bank, yet struggling to get above £3.50. It's all about timing on AIM"
Dave spot on. Pity nobody listened several months ago when I was saying it.
RE: New RNS - Successful completion of £6m Placing10 Sep 2021 19:23
Bit odd that Genedrive are doing a placing. I thought that a takeover by Beckman Coulter was in the offing. Or was that just pollocks?
I will not call out any of the ramping crew for the time being, suffice to say they should be ashamed of themselves for the amount of wishful nonsense they were posting. Optimistic at best and intentionally misleading at worst. Whilst those who thought objectively were frequently shouted down for "deramping" or "wanting to buy in lower"
"Labs have to test a new product, confirm a new supplier can supply the demand, check the supplier, agree terms, etc. BC don’t just need to sell $millions of Genedrive’s test, they have to convince labs to stop buying $millions of existing supplier’s tests."
Preefty it is a circa 2 hour covid test and we are in the middle of a Pandemic. They are not trying to broker the sale of used car ferries to Tajikistan!
The first shipment went over to the USA 6 months ago. Where are the sales figures?